Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers (UroPanc)

NCT04449406 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT04449406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04449406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers (UroPanc)
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2020
Completion date
August 31, 2026
Enrollment
3,500 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma